市场调查报告书
商品编码
993966

动物用抗生素及抗菌剂的全球市场

Animal Antibiotics and Antimicrobials

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

全球动物用抗生素及抗菌剂的市场规模,预计在分析期间(2020年~2027年)将以4.5%的年复合成长率增长,从2020年的44亿美元,到2027年达到59亿美元。

本报告所分析的市场区隔之一的四环霉素部门,在分析期间中预计将以5.4%的年复合成长率增长,达到14亿美元。

本报告提供全球动物用抗生素及抗菌剂市场的相关调查,提供市场占有率,Covid-19的影响,趋势和成长要素,各地区的市场分析,竞争情形,主要企业的简介等资讯。

调查对象企业范例

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi
  • Vetoquinol S.A.
  • Virbac
  • Zoetis, Inc.

目录

I. 调查手法

II. 摘要整理

  • 市场概要
    • 影响者市场洞察
    • 全球市场的轨迹
    • Covid-19的影响与即将到来的全球景气衰退
    • 竞争的市场占有率
    • 竞争的市场占有率方案
    • 竞争的市场占有率:各市场区隔
  • 主要企业
  • 趋势与推动要素
  • 全球市场预测

III. 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

IV. 竞争

  • 企业简介:36公司
目录
Product Code: MCP21139

Abstract:

Global Animal Antibiotics and Antimicrobials Market to Reach $5.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Animal Antibiotics and Antimicrobials estimated at US$4.4 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. Tetracycline, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Penicillin segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 7.4% CAGR

The Animal Antibiotics and Antimicrobials market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Macrolide Segment to Record 4.6% CAGR

In the global Macrolide segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$490.7 Million in the year 2020 will reach a projected size of US$662.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$789.2 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 36 Featured) -

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi
  • Vetoquinol S.A.
  • Virbac
  • Zoetis, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Animal Antibiotics and Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Animal Antibiotics and Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Animal Antibiotics and Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Tetracycline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Tetracycline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Tetracycline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Penicillin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Penicillin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Penicillin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Macrolide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Macrolide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Macrolide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Aminoglycoside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Aminoglycoside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Aminoglycoside by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Sulfonamide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Sulfonamide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Sulfonamide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Fluoroquinolone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Fluoroquinolone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Fluoroquinolone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 31: Japan Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Japan Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Japan 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 34: China Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: China Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: China 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 37: Europe Current & Future Analysis for Animal Antibiotics and Antimicrobials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 38: Europe Historic Review for Animal Antibiotics and Antimicrobials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Europe 15-Year Perspective for Animal Antibiotics and Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 40: Europe Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Europe Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Europe 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 43: France Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: France Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: France 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 46: Germany Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Germany Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Germany 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 49: Italy Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Italy Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Italy 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 52: UK Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: UK Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: UK 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 55: Spain Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Spain Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Spain 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 58: Russia Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Russia Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Russia 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 61: Rest of Europe Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Rest of Europe Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Rest of Europe 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 64: Asia-Pacific Current & Future Analysis for Animal Antibiotics and Antimicrobials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 65: Asia-Pacific Historic Review for Animal Antibiotics and Antimicrobials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Asia-Pacific 15-Year Perspective for Animal Antibiotics and Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 67: Asia-Pacific Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Asia-Pacific Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Asia-Pacific 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 70: Australia Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Australia Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Australia 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 73: India Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: India Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: India 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 76: South Korea Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: South Korea Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: South Korea 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 79: Rest of Asia-Pacific Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Asia-Pacific Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Rest of Asia-Pacific 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 82: Latin America Current & Future Analysis for Animal Antibiotics and Antimicrobials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 83: Latin America Historic Review for Animal Antibiotics and Antimicrobials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Latin America 15-Year Perspective for Animal Antibiotics and Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 85: Latin America Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Latin America Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Latin America 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 88: Argentina Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Argentina Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Argentina 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 91: Brazil Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Brazil Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Brazil 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 94: Mexico Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Mexico Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Mexico 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 97: Rest of Latin America Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Latin America Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Latin America 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 100: Middle East Current & Future Analysis for Animal Antibiotics and Antimicrobials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 101: Middle East Historic Review for Animal Antibiotics and Antimicrobials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Middle East 15-Year Perspective for Animal Antibiotics and Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 103: Middle East Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Middle East Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Middle East 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 106: Iran Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Iran Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Iran 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 109: Israel Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Israel Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Israel 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 112: Saudi Arabia Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Saudi Arabia Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Saudi Arabia 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 115: UAE Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UAE Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: UAE 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 118: Rest of Middle East Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Rest of Middle East Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: Rest of Middle East 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 121: Africa Current & Future Analysis for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Africa Historic Review for Animal Antibiotics and Antimicrobials by Product - Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: Africa 15-Year Perspective for Animal Antibiotics and Antimicrobials by Product - Percentage Breakdown of Value Sales for Tetracycline, Penicillin, Macrolide, Aminoglycoside, Sulfonamide, Fluoroquinolone and Other Products for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 36